Sharon Bio-Medicine informs about outcome of CoC

21 Nov 2022 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sharon Bio-Medicine has informed that the Committee of Creditors (CoC) of the company in the 21st CoC meeting held on 17th November 2022 have taken on records the voting results of the 20th CoC meeting dated 7th October 2022 wherein the Resolution Plan dated 22nd August 2022 as modified on 6th October 2022 stands approved with requisite majority as per Section 30(4) of the IBC, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×